The role of traditional medicine in the comprehensive treatment of patients with rheumatoid arthritis
Keywords:
arthritis, osteoarthritis, rheumatoid arthritisAbstract
Rheumatoid arthritis (RA) is a complex autoimmune disorder characterized by joint pain, swelling, and significant healthcare costs. Despite advancements in treatment, many patients experience uncontrolled disease activity, highlighting the need for personalized management strategies. Current approaches, including pharmacological therapies, have limitations, such as variable efficacy and potential adverse effects. This underscores the importance of exploring alternative treatment modalities.
Traditional medicine, particularly folk remedies and practices rooted in cultural contexts, may offer unique benefits when integrated into the treatment of RA. For instance, Tibetan medicine regards RA as a form of "Grum bu disease" and emphasizes dietary regulation and holistic interventions. Similarly, Chinese herbal medicine harnesses botanical resources like Tripterygium wilfordii and Curcuma longa to alleviate symptoms and potentially modify disease progression. The combination of Traditional Chinese Medicine (TCM) and Western medicine (WM) has shown promise in improving treatment outcomes and reducing side effects.
In addition to cultural practices, recent advancements in machine learning and deep learning models offer new opportunities to predict RA disease activity and tailor treatments to individual patients. The integration of these advanced technologies with holistic approaches may enhance disease management and improve patient quality of life.
In conclusion, the complex treatment of RA could benefit significantly from a multifaceted approach that incorporates traditional medicine, dietary modifications, and state-of-the-art predictive modeling to address the unique needs of each patient, providing a comprehensive framework for improving therapeutic outcomes in RA management.
Downloads
References
1. Kolasinski S.L., Neogi T., Hochberg M.C., Oatis C., Guyatt G., Block J., Callahan L., Copenhaver C., Dodge C., Felson D., Gellar K., Harvey W.F., Hawker G., Herzig E., Kwoh C.K., Nelson A.E., Samuels J., Scanzello C., White D., Wise B., Altman R.D., DiRenzo D., Fontanarosa J., Giradi G., Ishimori M., Misra D., Shah A.A., Shmagel A.K., Thoma L.M., Turgunbaev M., Turner A.S., Reston J. American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee // Arthritis Care & Research. – 2022. – Vol. 74, No. 2. – P. 222 [1].
2. Norgeot B., Glicksberg B.S., Trupin L., Lituiev D., Gianfrancesco M., Oskotsky B., Schmajuk G., Yazdany J., Butte A.J. Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis // Journal of the American Medical Informatics Association. – 2022. – Vol. 29, No. 2. – P. 1-9 [2].
3. Yu L., Li S., Pu L., Yang C., Shi Q., Zhao Q., Meniga S., Liu Y., Zhang Y., Lai X. Traditional Tibetan medicine: therapeutic potential in rheumatoid arthritis // Journal of Ethnopharmacology. – 2022. – Vol. 284. – P. 02-03 [3].
4. Xing Q., Fu L., Yu Z., Zhou X. Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis // Chinese Journal of Integrative Medicine. – 2022. – Vol. 28. – P. 315-324 [4].
5. Raslan M.A., Raslan S.A., Shehata E.M., Mahmoud A.S., Sabri N.A., Alzahrani K.J., Alzahrani F.M., Halawani I.F., Azevedo V., Lundstrom K., Barh D. Different modalities to manage rheumatoid arthritis: an A to Z story // Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases. – 2024. – Vol. 30, No. 1. – P. 4-8 [5].
6. Yu K., Yang K., Wang X., Han T., Wang W. Protocol for rheumatoid arthritis complicated with cardiovascular damage treated with Guanxining tablet with a randomized controlled trial // Chinese Journal of Integrated Traditional and Western Medicine. – 2022. – Vol. 42. – P. 45-50 [6].
7. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., Russell A., Dougados M., Emery P., Nuamah I.F., Williams G.R., Becker J-C., Hagerty D.T., Moreland L.W. Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig // The New England Journal of Medicine. – 2003. – Vol. 349, No. 24. – P. 1907-1917 [7].
